Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1985004 | 0.84 | — | — | |
| SCHEMBL12035115 | 0.84 | — | — | |
| SCHEMBL450125 | 0.84 | — | — | |
| SCHEMBL24844731 | 0.79 | ALDH1A1 (0.50) | — | |
| SCHEMBL9268731 | 0.78 | MAN1B1 (0.36) | CYP2C9MAN1B1 | |
| SCHEMBL18710271 | 0.78 | MAN1B1 (0.36) | CYP2C9MAN1B1 | |
| SCHEMBL338223 | 0.78 | MAN1B1 (0.36) | CYP2C9MAN1B1 | |
| SCHEMBL21388382 | 0.78 | MAN1B1 (0.36) | CYP2C9MAN1B1 | |
| Ammonia Solution, Strong SCHEMBL7958969 | 0.78 | — | — | |
| SCHEMBL21098299 | 0.76 | CYP2C9 (0.33) | CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11192918-B2 | Multicyclic peptides and methods for their preparation | STICHTING VOOR DE TECHNISCHE WETENSCHAPPEN (NL) | 2021-12-07 | — | — | US | disclosed |
| US-20200239516-A1 | Multicyclic Peptides and Methods for Their Preparation | UNIVERSITEIT VAN AMSTERDAM (NL) | 2020-07-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200239516-A1 | Multicyclic Peptides and Methods for Their Preparation | VIP, NGLY1, PTMS | CYP2C9 4798/4885MAN1B1 1224/4885 |
| US-11192918-B2 | Multicyclic peptides and methods for their preparation | VIP, NGLY1, PTMS | CYP2C9 4798/4885MAN1B1 1224/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.